Genetec Corp. (4492) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genetec Corp. (4492:JPX), powered by AI.

Current Price
¥375
P/E Ratio
10.2
Market Cap
4.3B
Sector
Technology
What is the Genetec Corp. stock price forecast?

Genetec Corp. is currently trading at ¥375. View real-time AI analysis on Alpha Lenz.

What is Genetec Corp. insider trading activity?

View the latest insider trading data for Genetec Corp. on Alpha Lenz.

What is Genetec Corp.'s P/E ratio?

Genetec Corp.'s P/E ratio is 10.2.

Genetec Corp.

JPX · 4492
¥375-10(-2.60%)Market closedJPX regular session 09:00–15:00 JST
Ask about Genetec Corp.'s future dividend policy...
Alpha Chat Insight

Genetec Corp. trades at a P/E of 10.2 (undervalued) with strong ROE of 18.2%. 3Y revenue CAGR of 20.2% highlights clear growth momentum.

Ask for details

Company Overview

Genetec Corp. is a prominent player in the biotechnology industry, focusing on the development, production, and commercialization of biopharmaceutical products. Genetec’s primary function is to innovate in the field of medical therapies, leveraging cutting-edge biotechnology to address chronic and life-threatening diseases. The company is heavily involved in research and development, driving advancements in areas such as cancer treatment, immunology, and genetic disorders. Its products are vital in catering to the pharmaceutical needs of healthcare facilities worldwide, impacting sectors such as healthcare, pharmaceuticals, and biotechnology research. As a significant entity in the financial market, Genetec Corp. contributes to the biotech sector's growth, influencing global healthcare trends. The company's efforts in pioneering drug innovations and clinical advancements play a critical role in improving patient outcomes and propelling medical science forward.

CEOMr. Kenji Ueno
SectorTechnology
IndustrySoftware - Application
Employees619

Company Statistics

FY 2025

Profile

¥4,289,706,750Market Cap
¥8,124,549,000Revenue
0.00Shares Out
619Employees

Margins

40.26%Gross
10.45%EBITDA
8.54%Operating
8.15%Pre-Tax
5.18%Net

Valuation

10.19P/E
1.78P/B
0.53EV/Sales
5.37EV/EBITDA
18.45P/FCF

Growth (CAGR)

20.16%Rev 3Yr
11.47%Rev 5Yr
53.95%Op Inc 3Yr
15.62%Op Inc 5Yr
95.18%Net Inc 3Yr
14.65%Net Inc 5Yr

Returns

7.22%ROA
18.24%ROE
11.54%ROIC

Financial Health

¥1,985,959,000Cash & Cash Equivalents
¥2,759,887,000Net Debt
197.46%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Genetec Corp. (ticker: 4492) is a company listed on JPX in the Technology sector (Software - Application). It has approximately 619 employees. Market cap is $4.3B.

The current price is 375 with a P/E ratio of 10.19x and P/B of 1.78x.

ROE is 18.24% and operating margin is 8.54%. Annual revenue is $8.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Genetec Corp. (4492) Stock Forecast 2026 ¥375 — Price, Financials & Analyst Targets | Alpha Lenz